Mark Sibbering

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

Robert E. Mansel, Lesley Fallowfield, Mark Kissin et al. · JNCI Journal of the National Cancer Institute · 2006 · 1.7K citations

Medicine, Oncology, Surgery +16

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

Ian Smith, J.F.R. Robertson, Lucy Kilburn et al. · The Lancet Oncology · 2020 · 317 citations · Full text

Medicine, Oncology, Pharmacology +17

Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.

Andy Evans, Sarah E. Pinder, R. Wilson et al. · American Journal of Roentgenology · 1994 · 123 citations

Medicine, Pathology, Radiology +16

Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ

Anthony Maxwell, Karen Clements, Bridget Hilton et al. · European Journal of Surgical Oncology · 2018 · 104 citations · Full text

Medicine, Oncology, Pathology +14

Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project

Alastair M. Thompson, Karen Clements, Shan Cheung et al. · European Journal of Cancer · 2018 · 78 citations · Full text

Medicine, Oncology, Surgery +7